Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study on the Effect of Sitagliptin on Maximal Beta Cell Stimulation

NCT00425490 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00425490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study on the Effect of Sitagliptin on Maximal Beta Cell Stimulation
Lead sponsor
Sheba Medical Center
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
July 31, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2